In this interview Robert Nelson, Associate Director of Science and Innovation at Covance (Geneva, Switzerland) discusses the importance of biomarkers in drug development, describing key aspects in the current guidance and key considerations to make in the development and validation process.
Browsing: assay development
Researchers from Baylor College of Medicine (TX, USA) have developed a novel technological approach that increases the number of molecular pathways that can be studied simultaneously by a luciferase assay from two to six.
In this feature, we explore the key qualities to look for to ensure success when outsourcing immunogenicity assay development and testing. We also explore the methods for – and challenges involved with – T-cell immunity monitoring and assay development.
In this podcast, Steven Kleiboeker (Vice-President of Research and Development at Viracor Eurofins BioPharma Services,…